Industrial Policy & Trade Monitor· 2673 actions· ✨ 90 recent

On 26 December 2025 the President of Kazakhstan signed a law amending the Code "On Subsoil and Subsoil Use" with respect to the hydrocarbon and uranium sectors, followed on 30 December 2025 by a parallel set of amendments implementing presidential instructions on broader subsoil-use governance. Both packages take effect on 2 March 2026. The uranium amendments grant the National Atomic Company Kazatomprom (KAP) a statutory priority right to obtain exploration licences over prospective uranium areas listed in the State Subsoil Fund Management Programme, and to reserve blocks containing uranium mineralisation or deposits. Where uranium mineralisation is discovered on a solid-mineral block held by a third-party subsoil-user, an extension of that licence is conditional on the licensee surrendering the uranium-bearing block to the State; private subsoil-users no longer obtain priority production rights for uranium they discover. The amendments also raise the minimum direct or indirect Kazatomprom interest in any uranium mining project from 50% to 75%, and permit subsequent transfer to investors or joint-venture partners only subject to that 75% floor. The 30 December 2025 package establishes the National Geological Service as a non-privatisable national operator subordinate to the authorised subsoil-exploration agency and as the operator responsible for managing geological information; it also creates a Unified Subsoil Use Platform digital infrastructure (open geological-information database integrated with the Unified State System for Management of the Fuel and Energy Complex). The hydrocarbon track of the law shortens block-reservation periods and pushes unallocated plots into electronic-auction allocation to accelerate competitive exploration. The amendments accompany an announced USD 500m state geological-exploration programme.

Taiwan's Legislative Yuan passed the Artificial Intelligence Basic Act (人工智慧基本法) on third reading on 23 December 2025, and President Lai Ching-te promulgated the 20-article statute on 14 January 2026, bringing it into force immediately. The Act designates the National Science and Technology Council (NSTC) as the central AI-policy competent authority and codifies seven governance principles — sustainability and well-being, human autonomy, privacy protection and data governance, cybersecurity and safety, transparency and explainability, fairness and non-discrimination, and accountability — that apply to all public-sector AI procurement and high-risk sectoral applications. The statute establishes a statutory foundation for the Taiwan AI Action Plan 2.0, mandates an Executive Yuan National AI Strategy Committee, and provides authority for sector-specific implementing regulations by FSC, NCC, MOHW, and MOTC across finance, telecoms, medical, and autonomous-vehicle AI within a two-year window. As the first national AI governance statute in the Greater China region and the third globally after the EU AI Act and South Korea's AI Basic Act, it frames regulatory expectations for the companies at the heart of the global AI hardware supply chain — TSMC, NVIDIA ODM partners, and advanced-packaging incumbents — that are headquartered or operate substantially in Taiwan.

In the early hours of 11 December 2025 the Council of the EU and the European Parliament reached provisional political agreement in trilogue on the "EU Pharma Package" — the revised pharmaceutical Regulation (COM 2023/0131) and Directive (COM 2023/0132) — the most significant overhaul of EU pharmaceutical legislation in over two decades. The package replaces Directive 2001/83/EC (Community Code on medicinal products for human use) and Regulation (EC) 726/2004 (the EMA Regulation), and consolidates the orphan-medicine (Regulation 141/2000) and pediatric-medicine regulations into a single framework. Headline provisions: (i) a new "8+1(+1)(+1)" IP-incentive architecture — 8 years of regulatory data protection plus 1 year of market protection, with up to two additional 12-month extensions for products addressing unmet medical need or new active substances meeting comparative-trial conditions, capped at 11 years total; (ii) an EU-wide list of critical medicines under enhanced governance via the Medicines Shortages Steering Group (MSSG) and an EMA "list of critical shortages in the EU"; (iii) mandatory shortage-prevention plans on marketing-authorisation holders for prescription medicines and Commission-designated products; (iv) modernisation of clinical-trial requirements, environmental-risk assessment, antimicrobial stewardship, and a transferable-exclusivity-voucher (TEV) regime to incentivise novel antibiotic R&D. The COREPER I committee endorsed the compromise text on 6 March 2026 and final adoption by Parliament and Council is expected during summer 2026, with the regulatory framework becoming applicable in 2028.

On 20 November 2025 the White House and US Department of Commerce / Bureau of Industry and Security (BIS) authorised Abu Dhabi AI holding company G42 to import advanced computing chips — equivalent to approximately 35,000 Nvidia GB300 Blackwell processors — under the UAE-pioneered Regulated Technology Environment (RTE) compliance framework. The RTE is an Emirati-designed technology governance and audit architecture, developed by G42 and approved under BIS guidelines, with binding UAE-side controls to prevent onward diversion to foreign adversary nations. The authorisation accelerates the Stargate UAE project — a 1 GW AI compute cluster being built by G42 for OpenAI in partnership with Oracle, Cisco, NVIDIA, and SoftBank Group — and represents the first concluded major country-level advanced-compute authorisation following the May 2025 rescission of the Biden-era AI Diffusion Rule.

India and the UK signed the Comprehensive Economic and Trade Agreement (CETA) on 24 July 2025 in Chequers, with Prime Ministers Modi and Starmer presiding. The agreement grants duty-free access on 99% of Indian exports to the UK (textiles, apparel, footwear, auto components, engineering goods and chemicals), and reduces Indian tariffs on UK goods covering ~90% of tariff lines: Scotch whisky duties drop from 150% to 75% on day one and taper to 40% over ten years; high-end UK car tariffs fall from ~110% to 10% under a quota; UK MFN access on a wide industrial-goods envelope. A Double Contribution Convention exempts Indian secondees from UK National Insurance for three years. Bilateral trade currently ~£42 bn / USD 56 bn per year, with the parties targeting doubling by 2030. UK ratification under the Constitutional Reform and Governance Act 2010 (CRaG) ran from January 2026, with the 21-sitting-day scrutiny period concluding 5 March 2026. Entry into force was delayed from the originally targeted May 2026 date and is now confirmed for July 15, 2026 following a UK Prime Minister announcement at the G7 Évian summit sidelines on June 17, 2026. The confirmed EIF covers 64% of UK exports (£1.9bn) duty-free immediately, with an additional £25.5bn/year in projected additional bilateral trade.

On 24 February 2025 President Prabowo Subianto launched Badan Pengelola Investasi Daya Anagata Nusantara (Danantara), Indonesia's new state investment-management agency, consolidating around USD 900bn–1tn of Indonesian state-owned-enterprise assets — including Pertamina, PLN, Bank Mandiri, BRI, BNI, Telkom, MIND ID, Antam and Inalum — into a single super-holding modelled on Singapore's Temasek. Danantara was created by the Third Amendment to the BUMN Law (Law No. 1 of 2025, enacted 24 February 2025) and Government Regulation No. 10 of 2025 on its organisation and governance, with board appointments formalised by Presidential Regulation No. 30 of 2025. The agency reports directly to the President, bypassing the Ministry of State-Owned Enterprises, and is mandated to deploy SOE balance-sheet capacity into Prabowo's 8% growth target via co-investment in mineral downstreaming, refinery and EV-battery build-out, food security, and semiconductor / data-centre infrastructure.

On 1 February 2025, Finance Minister Nirmala Sitharaman announced the National Manufacturing Mission (NMM) in the Union Budget 2025-26 as a horizontal umbrella framework extending the 2014 "Make in India" architecture across small, medium and large industries. The mission rests on five focal areas: (i) ease and cost of doing business; (ii) a future-ready workforce for in-demand jobs; (iii) a vibrant and dynamic MSME sector; (iv) availability of technology; and (v) quality manufacturing. It will deliver policy support, execution roadmaps, and a governance/monitoring framework binding central ministries with states. NMM specifically commits to building a clean-tech manufacturing ecosystem with explicit coverage of solar PV cells, EV batteries, motors and controllers, electrolysers, wind turbines, very-high-voltage transmission equipment, and grid-scale batteries — i.e., the full hardware stack for India's Panchamrit (500 GW non-fossil by 2030), FAME-III EV ramp, and National Green Hydrogen Mission. NMM is the first horizontal Indian manufacturing-mission instrument in the IPTM register; existing IND entries are sector-specific PLIs (electronics, batteries, steel, semiconductors) and the National Critical Mineral Mission. Operational rollout flows through subsequent Cabinet-level scheme approvals (e.g. Biopharma SHAKTI ₹10,000 cr, Chemical Parks ₹600 cr in BE 2026-27); the mission itself does not carry a single headline outlay because it is the framework rather than an instrument.